Dr. Cirstea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Mount Auburn HospitalResidency, Internal Medicine, 2013 - 2016
Nicolae Testemitanu State University of Medicine and PharmacyClass of 2000
Certifications & Licensure
MA State Medical License 2013 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 163 citationsThe monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo.Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, Robert J. Lutz, Hiroshi Yasui
Clinical Cancer Research. 2009-06-15 - 483 citationsPreclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myelomaLoredana Santo, Teru Hideshima, Andrew L. Kung, Jen-Chieh Tseng, David Tamang
Blood. 2012-03-15 - 121 citationsHistone deacetylase 3 as a novel therapeutic target in multiple myeloma.Jiro Minami, Rikio Suzuki, Ralph Mazitschek, Gullu Gorgun, Balaram Ghosh
Leukemia. 2014-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
